Shin Matsuda

731 total citations
44 papers, 321 citations indexed

About

Shin Matsuda is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Shin Matsuda has authored 44 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 14 papers in Genetics and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Shin Matsuda's work include Acute Myeloid Leukemia Research (12 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Shin Matsuda is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Shin Matsuda collaborates with scholars based in Japan, Greece and United States. Shin Matsuda's co-authors include S Kariyone, Tatsumi Uchida, Toshiyuki Ishibashi, Ryuzo Ohno, Norio Asou, Shuichi Miyawaki, Hideo Kimura, Tadashi Sato, Shigeki Ohtake and Kinuko Mitani and has published in prestigious journals such as Blood, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Shin Matsuda

41 papers receiving 315 citations

Peers

Shin Matsuda
B M Camitta United States
A. Basch France
C Béhar France
A Granda Spain
S-J Choi South Korea
Jaime Estrada United States
B M Camitta United States
Shin Matsuda
Citations per year, relative to Shin Matsuda Shin Matsuda (= 1×) peers B M Camitta

Countries citing papers authored by Shin Matsuda

Since Specialization
Citations

This map shows the geographic impact of Shin Matsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin Matsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin Matsuda more than expected).

Fields of papers citing papers by Shin Matsuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin Matsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin Matsuda. The network helps show where Shin Matsuda may publish in the future.

Co-authorship network of co-authors of Shin Matsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Shin Matsuda. A scholar is included among the top collaborators of Shin Matsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin Matsuda. Shin Matsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanemasa, Yusuke, Yasushi Yagi, Kensei Taguchi, et al.. (2024). Radiation Therapy as a Bridging Strategy in CAR-T Cell Therapy and the Impact of Tumor Control Status at CAR-T Cell Infusion. International Journal of Radiation Oncology*Biology*Physics. 120(2). S207–S207.
2.
Endo, Noriko, Aya Goto, Tomoko Suzuki, Shin Matsuda, & Seiji Yasumura. (2015). Factors Associated With Enrollment and Adherence in Outpatient Cardiac Rehabilitation in Japan. Journal of Cardiopulmonary Rehabilitation and Prevention. 35(3). 186–192. 13 indexed citations
3.
Takamura, Ayumi, Norio Sakai, Atsuko Noguchi, et al.. (2013). The useful preliminary diagnosis of Niemann-Pick disease type C by filipin test in blood smear. Molecular Genetics and Metabolism. 110(3). 401–404. 7 indexed citations
4.
Sakamaki, Hisashi, Shuichi Miyawaki, Shigeki Ohtake, et al.. (2010). Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study. International Journal of Hematology. 91(2). 284–292. 25 indexed citations
5.
Ohtake, Shigeki, Shuichi Miyawaki, Hitoshi Kiyoi, et al.. (2010). Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study. International Journal of Hematology. 91(2). 276–283. 19 indexed citations
6.
Nagai, Hirokazu, Michinori Ogura, Shigeru Kusumoto, et al.. (2010). Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma. European Journal Of Haematology. 86(2). 117–123. 5 indexed citations
7.
Kobayashi, Yukio, Kensei Tobinai, Akihiro Takeshita, et al.. (2009). Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study. International Journal of Hematology. 89(4). 460–469. 19 indexed citations
8.
Sakamaki, Hisashi, Shuichi Miyawaki, Shigeki Ohtake, et al.. (2008). Allogeneic Stem Cell Transplantation (Allo-SCT) in Adults with Acute Myelogenous Leukemia (AML). Final Analysis of JALSG AML97 Study. Blood. 112(11). 347–347. 2 indexed citations
10.
Suzuki, Ritsuro, Makoto Murata, Masahiro Kami, et al.. (2003). Prognostic Significance of CD7+CD56+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0. International Journal of Hematology. 77(5). 482–489. 23 indexed citations
11.
Yamada, Hisakata, et al.. (1995). [A case of nephrotic syndrome associated with severe interstitial pneumonitis due to cyclophosphamide whose life was saved by steroid pulse therapy].. PubMed. 37(9). 518–22. 1 indexed citations
12.
Yasuda, Hiroyasu, et al.. (1991). Effective prophylaxis against the development of alloantibodies with leukocyte-depleted blood components by filtration.. Journal of the Japan Society of Blood Transfusion. 37(4). 501–505. 1 indexed citations
14.
Uchida, Tatsumi, et al.. (1988). Ferrokinetic Evaluation of Erythropoiesis in Patients with Myelodysplastic Syndromes. Acta Haematologica. 79(2). 81–83. 1 indexed citations
15.
Uchida, Tatsumi, et al.. (1987). Intravascular survival of leukemic cells labeled with Indium-111-oxine. Annals of Nuclear Medicine. 1(1). 33–38. 1 indexed citations
16.
Ishibashi, Toshiyuki, et al.. (1987). Megakaryocytic colony formation (CFU‐Meg) in essential thrombocythemia: Quantitative and qualitative abnormalities of bone marrow CFU‐Meg. American Journal of Hematology. 24(1). 23–30. 37 indexed citations
17.
Kimura, Kazuhiro, Takashi Sato, Shin Matsuda, et al.. (1985). A case of adult T-cell leukemia with metastatic calcification. European Journal of Nuclear Medicine and Molecular Imaging. 10(1-2). 90–2. 7 indexed citations
18.
Uchida, Tatsumi, et al.. (1982). Detection of platelet consumption in aortic graft with 111In-labeled platelets. European Journal of Nuclear Medicine and Molecular Imaging. 7(2). 77–9. 7 indexed citations
19.
Uchida, Tatsumi, et al.. (1979). Use of technetium-99m as a radioactive label to study migratory patterns of leukocytes.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(11). 1197–200. 9 indexed citations
20.
Matsuda, Shin. (1951). Studies on the Aberration of the Ovarian Function Caused by Repeated Irritation. Folia Endocrinologica Japonica. 27(3). 45–62_1,85. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026